A protein therapeutics company developing treatments for Duchenne and Becker Muscular Dystrophies and other neuromuscular disorders
1
Funding Rounds
$1.0m
Money raised
The company Tivorsan Pharmaceuticals has raised a total of $1m in funding over 1 rounds.